Related Experiment Video
Updated: Mar 13, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma
Luisa Vicari1, Cristina La Rosa2, Stefano Forte1
1IOM Ricerca srl, Viagrande CT, Italy.
Background:
Activating transcription factor 5 (ATF5) is a member of the activating transcription/cAMP response element-binding protein family of basic leucine zipper proteins that plays an important role in cell survival, differentiation, proliferation, and apoptosis. The ATF5 gene generates two transcripts: ATF5 isoform 1 and ATF5 isoform 2. A number of studies indicate that ATF5 could be an attractive target for therapeutic intervention in several tumor types; however, so far, the role of ATF5 has not been investigated in papillary thyroid carcinoma (PTC).
Methods:
Quantitative real-time reverse transcription polymerase chain reaction and immuno-histochemical staining were used to study ATF5 mRNA and protein expression in PTC.
Results:
We report here that ATF5 is expressed more in PTC tissue than in normal thyroid tissue. Furthermore, this is the first study that describes the presence of both ATF5 isoforms in PTC.
Conclusion:
These findings could provide potential applications in PTC cancer treatment.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
General Transcription Factors
Master Transcription Regulators
TGF - β Signaling Pathway
Transcription Factors
Cell Specific Gene Expression

